Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Ever Supreme Bio Technology Co., Ltd. (6712) Financial Statements

Ever Supreme Bio Technology Co., Ltd. Financial Overview

Ever Supreme Bio Technology Co., Ltd.'s market cap is currently NT$14.92B. The company's EPS TTM is NT$5.06; its P/E ratio is 30.86; and it has a dividend yield of 2.14%. Ever Supreme Bio Technology Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 1.02BNT$ 933.81MNT$ 758.39MNT$ 627.51MNT$ 438.84M
Gross ProfitNT$ 721.33MNT$ 660.04MNT$ 484.75MNT$ 414.56MNT$ 245.48M
Operating IncomeNT$ 439.00MNT$ 421.19MNT$ 337.73MNT$ 264.61MNT$ 397.44M
EBITDANT$ 462.17MNT$ 491.76MNT$ 655.52MNT$ 300.16MNT$ 433.26M
Net IncomeNT$ 429.43MNT$ 367.25MNT$ 539.40MNT$ 200.71MNT$ 369.60M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 435.66MNT$ 938.17MNT$ 1.34BNT$ 1.27BNT$ 1.34B
Total AssetsNT$ 2.00BNT$ 2.14BNT$ 2.08BNT$ 1.97BNT$ 2.02B
Total DebtNT$ 38.75MNT$ 2.84MNT$ 5.90MNT$ 17.86MNT$ 34.42M
Net DebtNT$ -183.41MNT$ -298.83MNT$ -330.54MNT$ -335.71MNT$ -606.69M
Total LiabilitiesNT$ 477.80MNT$ 341.82MNT$ 232.96MNT$ 181.45MNT$ 124.83M
Stockholders' EquityNT$ 1.53BNT$ 1.79BNT$ 1.84BNT$ 1.79BNT$ 1.90B
Cash Flow
Free Cash FlowNT$ 530.62MNT$ 434.78MNT$ 415.91MNT$ 313.61MNT$ 131.04M
Operating Cash FlowNT$ 536.35MNT$ 440.34MNT$ 421.74MNT$ 319.20MNT$ 135.69M
Investing Cash FlowNT$ 134.27MNT$ -23.46MNT$ 61.60MNT$ -287.31MNT$ -296.83M
Financing Cash FlowNT$ -750.13MNT$ -451.64MNT$ -500.47MNT$ -319.43MNT$ 733.36M

Currency in TWD

Ever Supreme Bio Technology Co., Ltd. Earnings and Revenue History

-600M0600M1.2B-1000 %-500 %0 %500 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Ever Supreme Bio Technology Co., Ltd. Liabilities to Assets

0800M1.6B2.4B0 %10 %20 %30 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Ever Supreme Bio Technology Co., Ltd. Cash Flow

-1B-500M0500M1B2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Ever Supreme Bio Technology Co., Ltd. Forecast EPS vs Actual EPS

0.50.811.31.51.822.3Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >